Wntless (GPR177) expression correlates with poor prognosis in B-cell precursor acute lymphoblastic leukemia via Wnt signaling

Carcinogenesis

Volumn 35, Issue 10, 2014, Pages 2357-2364

  Chiou, Shyh Shin ^a,b   Wang, Li Ting ^a   Huang, Shih Bo ^a   Chai, Chee Yin ^a   Wang, Shen Nien ^b,c   Liao, Yu Mei ^b   Lin, Pei Chin ^b   Liu, Kwei Yan ^a   Hsu, Shih Hsien ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Faculty of Medicine   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GPR177 PROTEIN; HEMOGLOBIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNTLESS PROTEIN; G PROTEIN COUPLED RECEPTOR; GPR177 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOGENIC ACTIVITY; CELL ISOLATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHILD; CONTROLLED STUDY; DEATH; FEMALE; GENE OVEREXPRESSION; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SPLENOMEGALY; THROMBOCYTE COUNT; WNT SIGNALING PATHWAY; ANIMAL; CASE CONTROL STUDY; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MORTALITY; NUDE MOUSE; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; TUMOR RECURRENCE;

ANIMALS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, NUDE; NEOPLASM RECURRENCE, LOCAL; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECEPTORS, G-PROTEIN-COUPLED; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84925822644     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu166     Document Type: Article

References (31)

1. Institute., N.C. SEER cancer statistics review 1975-2008. (http://www.seer.cancer.gov/csr/1975_2008).
2. Nakano, T.A. et al. (2012) Blood consult: therapeutic strategy and complications in the adolescent and young adult with acute lymphoblastic leukemia. Blood, 119, 4372-4374.
3. Brüggemann, M. et al. (2012) Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle. Semin. Oncol., 39, 47-57.
4. Diller, L. (2011) Clinical practice. Adult primary care after childhood acute lymphoblastic leukemia. N. Engl. J. Med., 365, 1417-1424.
5. Klaus, A. et al. (2008) Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer, 8, 387-398.
6. Lindvall, C. et al. (2007) Wnt signaling, stem cells, and the cellular origin of breast cancer. Stem Cell Rev., 3, 157-168.
7. Lustig, B. et al. (2003) The Wnt signaling pathway and its role in tumor development. J. Cancer Res. Clin. Oncol., 129, 199-221.
8. Polakis, P. (2007) The many ways of Wnt in cancer. Curr. Opin. Genet. Dev., 17, 45-51.
9. Brandon, C. et al. (2000) WNT signaling modulates the diversification of hematopoietic cells. Blood, 96, 4132-4141.
10. Luis, T.C. et al. (2009) Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. Blood, 113, 546-554.
11. Bänziger, C. et al. (2006) Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell, 125, 509-522.
12. Eaton, S. (2008) Retromer retrieves wntless. Dev. Cell, 14, 4-6.
13. Bartscherer, K. et al. (2006) Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell, 125, 523-533.
14. Hausmann, G. et al. (2007) Helping Wingless take flight: how WNT proteins are secreted. Nat. Rev. Mol. Cell Biol., 8, 331-336.
15. Yang, P.T. et al. (2008) Wnt signaling requires retromer-dependent recycling of MIG-14/Wntless in Wnt-producing cells. Dev. Cell, 14, 140-147.
16. Fu, J. et al. (2009) Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. Proc. Natl. Acad. Sci. USA., 106, 18598-18603.
17. Augustin, I. et al. (2012) The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis. EMBO Mol. Med., 4, 38-51.
18. Wang, L.T., et al. (2012) Functional characterization of mammalian Wntless homolog in mammalian system. Kaohsiung J. Med. Sci., 28, 355-361.
19. Hsu, S.H. et al. (2013) Proinflammatory homeobox gene, ISX, regulates tumor growth and survival in hepatocellular carcinoma. Cancer Res., 73, 508-518.
20. Hsu, S.H. et al. (2005) bHLH-zip transcription factor Spz1 mediates mitogen-activated protein kinase cell proliferation, transformation, and tumorigenesis. Cancer Res., 65, 4041-4050.
21. Wang, L.T. et al. (2011) Functional interaction of Ugene and EBV infection mediates tumorigenic effects. Oncogene, 30, 2921-2932.
22. Li, H.P. et al. (2013) Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma. Oncotarget, 4, 2154-2165.
23. Cadigan, K.M. et al. (2009) Wnt signaling from development to disease: insights from model systems. Cold Spring Harb. Perspect. Biol., 1, a002881.
24. Baba, Y. et al. (2005) Constitutively active beta-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors. Immunity, 23, 599-609.
25. Khan, N.I. et al. (2007) Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br. J. Haematol., 138, 338-348.
26. Gandhirajan, R.K. et al. (2010) Wnt/β-catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options. Curr. Cancer Drug Targets, 10, 716-727.
27. Lu, D. et al. (2004) Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA., 101, 3118-3123.
28. Sercan, Z. et al. (2009) Beta-catenin mutations are not observed in chronic myeloid leukemia. Tumori, 95, 836-839.
29. Taelman, V.F. et al. (2010) Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell, 143, 1136-1148.
30. Harterink, M. et al. (2011) A SNX3-dependent retromer pathway mediates retrograde transport of the Wnt sorting receptor Wntless and is required for Wnt secretion. Nat. Cell Biol., 13, 914-923.
31. Seaman, M.N. (2012) The retromer complex-endosomal protein recycling and beyond. J. Cell Sci., 125(Pt 20), 4693-4702.